News
NervGen Pharma Corp. , a clinical-stage biotech company dedicated to developing neuroreparative therapeutics, today announced positive topline results from the chronic cohort (1-10 years post injury) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback